Live Breaking News & Updates on Samarpan majumder

Stay updated with breaking news from Samarpan majumder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New approach for treatment-resistant breast cancers

New approach for treatment-resistant breast cancers
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Samarpan-majumder , Giulia-monticone , Fokhrul-hossain , Lucio-miele , Dorota-wyczechowska , Jovanny-zabaleta , Luis-del-valle , Health-new-orleans-school-of-medicine , Health-new-orleans , University-of-rochester

Research suggests a new approach for treatment-resistant breast cancers

Research suggests a new approach for treatment-resistant breast cancers
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United-states , Switzerland , American , Lucio-miele , Samarpan-majumder , Michele-vigolo , Health-new-orleans-school-of-medicine , University-of-rochester , Miele , New-orleans-school , Cellestia-biotech , Assistant-dean

LSU Health Research suggests a new approach f

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively.

Baton-rouge , Louisiana , United-states , Lafayette , New-orleans , Switzerland , American , Luis-del-valle , Fokhrul-hossain , Jovanny-zabaleta , Lucio-miele , Giulia-monticone

New treatment approach shows promise in reversing hormone resistance in breast cancer

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively.

Switzerland , United-states , American , Jovanny-zabaleta , Giulia-monticone , Fokhrul-hossain , Luis-del-valle , Samarpan-majumder , Dorota-wyczechowska , Danielle-ellis , Lucio-miele , University-of-rochester

LSU Health Research suggests a new approach f

LSU Health Research suggests a new approach f
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Lafayette , Louisiana , United-states , Baton-rouge , Switzerland , New-orleans , American , Samarpan-majumder , Fokhrul-hossain , Jovanny-zabaleta , Luis-del-valle , Lucio-miele

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

Massachusetts , United-states , California , University-of-massachusetts , Fred-csibi , Hamid-boulares , Keli-xu , Emily-henderson , Fokhrul-hossain , Ameya-champhekar , Nick-carpino , Giulia-monticone